vs

Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.

Silvercrest Asset Management Group Inc. is the larger business by last-quarter revenue ($32.0M vs $31.1M, roughly 1.0× LIFECORE BIOMEDICAL, INC. \DE\). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -32.1%, a 31.7% gap on every dollar of revenue. On growth, Silvercrest Asset Management Group Inc. posted the faster year-over-year revenue change (-0.0% vs -4.5%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $25.0K). Over the past eight quarters, Silvercrest Asset Management Group Inc.'s revenue compounded faster (2.7% CAGR vs -0.1%).

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

LFCR vs SAMG — Head-to-Head

Bigger by revenue
SAMG
SAMG
1.0× larger
SAMG
$32.0M
$31.1M
LFCR
Growing faster (revenue YoY)
SAMG
SAMG
+4.5% gap
SAMG
-0.0%
-4.5%
LFCR
Higher net margin
SAMG
SAMG
31.7% more per $
SAMG
-0.4%
-32.1%
LFCR
More free cash flow
SAMG
SAMG
$14.9M more FCF
SAMG
$15.0M
$25.0K
LFCR
Faster 2-yr revenue CAGR
SAMG
SAMG
Annualised
SAMG
2.7%
-0.1%
LFCR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
LFCR
LFCR
SAMG
SAMG
Revenue
$31.1M
$32.0M
Net Profit
$-10.0M
$-120.0K
Gross Margin
25.0%
Operating Margin
-9.9%
-2.8%
Net Margin
-32.1%
-0.4%
Revenue YoY
-4.5%
-0.0%
Net Profit YoY
-52.0%
-107.4%
EPS (diluted)
$-0.29
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFCR
LFCR
SAMG
SAMG
Q4 25
$32.0M
Q3 25
$31.1M
$31.3M
Q2 25
$30.7M
Q1 25
$35.2M
$31.4M
Q4 24
$32.6M
$32.0M
Q3 24
$24.7M
$30.4M
Q2 24
$31.0M
Q1 24
$35.7M
$30.3M
Net Profit
LFCR
LFCR
SAMG
SAMG
Q4 25
$-120.0K
Q3 25
$-10.0M
$618.0K
Q2 25
$1.9M
Q1 25
$-14.8M
$2.5M
Q4 24
$-6.6M
$1.6M
Q3 24
$-16.2M
$2.3M
Q2 24
$2.7M
Q1 24
$15.6M
$3.0M
Gross Margin
LFCR
LFCR
SAMG
SAMG
Q4 25
Q3 25
25.0%
Q2 25
Q1 25
28.0%
Q4 24
34.0%
Q3 24
21.8%
Q2 24
Q1 24
33.3%
Operating Margin
LFCR
LFCR
SAMG
SAMG
Q4 25
-2.8%
Q3 25
-9.9%
4.3%
Q2 25
13.2%
Q1 25
-25.7%
15.4%
Q4 24
-6.0%
6.1%
Q3 24
-46.9%
14.6%
Q2 24
17.1%
Q1 24
-2.5%
19.5%
Net Margin
LFCR
LFCR
SAMG
SAMG
Q4 25
-0.4%
Q3 25
-32.1%
2.0%
Q2 25
6.3%
Q1 25
-42.0%
7.9%
Q4 24
-20.2%
5.1%
Q3 24
-65.7%
7.4%
Q2 24
8.6%
Q1 24
43.8%
9.9%
EPS (diluted)
LFCR
LFCR
SAMG
SAMG
Q4 25
$0.02
Q3 25
$-0.29
$0.07
Q2 25
$0.21
Q1 25
$-0.47
$0.26
Q4 24
$-0.25
$0.16
Q3 24
$-0.53
$0.24
Q2 24
$0.28
Q1 24
$0.42
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFCR
LFCR
SAMG
SAMG
Cash + ST InvestmentsLiquidity on hand
$18.9M
$44.1M
Total DebtLower is stronger
$136.0M
Stockholders' EquityBook value
$-10.5M
$50.3M
Total Assets
$235.2M
$166.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFCR
LFCR
SAMG
SAMG
Q4 25
$44.1M
Q3 25
$18.9M
$36.1M
Q2 25
$30.0M
Q1 25
$5.4M
$36.3M
Q4 24
$9.5M
$68.6M
Q3 24
$58.1M
Q2 24
$49.9M
Q1 24
$39.7M
Total Debt
LFCR
LFCR
SAMG
SAMG
Q4 25
Q3 25
$136.0M
Q2 25
Q1 25
$124.9M
Q4 24
$111.3M
Q3 24
$106.3M
Q2 24
Q1 24
$97.1M
Stockholders' Equity
LFCR
LFCR
SAMG
SAMG
Q4 25
$50.3M
Q3 25
$-10.5M
$58.9M
Q2 25
$64.6M
Q1 25
$2.2M
$80.0M
Q4 24
$15.4M
$80.7M
Q3 24
$-3.9M
$84.6M
Q2 24
$85.3M
Q1 24
$17.7M
$83.9M
Total Assets
LFCR
LFCR
SAMG
SAMG
Q4 25
$166.6M
Q3 25
$235.2M
$157.6M
Q2 25
$152.7M
Q1 25
$237.7M
$159.9M
Q4 24
$255.4M
$194.4M
Q3 24
$246.8M
$184.2M
Q2 24
$177.6M
Q1 24
$246.2M
$170.2M
Debt / Equity
LFCR
LFCR
SAMG
SAMG
Q4 25
Q3 25
Q2 25
Q1 25
56.05×
Q4 24
7.20×
Q3 24
Q2 24
Q1 24
5.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFCR
LFCR
SAMG
SAMG
Operating Cash FlowLast quarter
$1.8M
$18.6M
Free Cash FlowOCF − Capex
$25.0K
$15.0M
FCF MarginFCF / Revenue
0.1%
46.9%
Capex IntensityCapex / Revenue
5.6%
11.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-16.8M
$17.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFCR
LFCR
SAMG
SAMG
Q4 25
$18.6M
Q3 25
$1.8M
$14.6M
Q2 25
$13.8M
Q1 25
$1.2M
$-24.7M
Q4 24
$-6.1M
$21.6M
Q3 24
$-613.0K
$13.3M
Q2 24
$16.0M
Q1 24
$-1.4M
$-24.1M
Free Cash Flow
LFCR
LFCR
SAMG
SAMG
Q4 25
$15.0M
Q3 25
$25.0K
$13.8M
Q2 25
$13.4M
Q1 25
$-4.3M
$-25.1M
Q4 24
$-8.6M
$19.9M
Q3 24
$-4.0M
$12.9M
Q2 24
$15.6M
Q1 24
$-7.8M
$-24.7M
FCF Margin
LFCR
LFCR
SAMG
SAMG
Q4 25
46.9%
Q3 25
0.1%
44.1%
Q2 25
43.6%
Q1 25
-12.1%
-80.0%
Q4 24
-26.3%
62.2%
Q3 24
-16.3%
42.4%
Q2 24
50.4%
Q1 24
-21.8%
-81.6%
Capex Intensity
LFCR
LFCR
SAMG
SAMG
Q4 25
11.4%
Q3 25
5.6%
2.6%
Q2 25
1.5%
Q1 25
15.5%
1.3%
Q4 24
7.5%
5.3%
Q3 24
13.9%
1.2%
Q2 24
1.1%
Q1 24
17.8%
2.0%
Cash Conversion
LFCR
LFCR
SAMG
SAMG
Q4 25
Q3 25
23.62×
Q2 25
7.22×
Q1 25
-10.01×
Q4 24
13.34×
Q3 24
5.90×
Q2 24
6.00×
Q1 24
-0.09×
-8.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

SAMG
SAMG

Investment Advisory Management And Administrative Service$30.7M96%
Tax And Family Office Services$1.2M4%

Related Comparisons